RxDoctor Payments Data

Javad Khalilzadeh, MD

Gastroenterology · Washington, DCNPI 1376528026

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 15 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 6 manufacturers reported payments, led by AbbVie at 44.1% of the total. Reporting peaked in 2019 at $357 and has fallen 92.4% since, to $27 in 2025. That places this record below the midpoint for gastroenterology clinicians in DC, where the typical reported total is $1,183.

$595in general payments, 2019–2025

Across 15 payments — averaging $39.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$263
  • Pentax Of America, Inc.$126
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$90
  • Takeda Pharmaceuticals U.S.A., Inc.$54
  • Ferring Pharmaceuticals Inc.$37
  • Exact Sciences$27

What the payments were for

  • Food & beverage$595100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$595 in reported general payments places this provider in the 35th percentile of 77 gastroenterology providers in District of Columbia.

See all gastroenterology providers in District of Columbia

Medicare billing

Part B allowed, 2024
$615,217
Medicare patients
550
Services billed
5,862

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl25$341
Procto-Med HcHydrocortisone13$289
Pantoprazole Sodium24$267
Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl12$194

Paid to pharmacies, not to this prescriber.

Other gastroenterology in Washington

See the full list for District of Columbia

Where these figures come from

Is this you, or does something look wrong? →